GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $155 | +21.1% | 40 | 0.0% | 0.00% | – |
Q2 2021 | $128 | +47.1% | 40 | 0.0% | 0.00% | – |
Q1 2021 | $87 | -3.3% | 40 | 0.0% | 0.00% | – |
Q4 2020 | $90 | -15.9% | 40 | 0.0% | 0.00% | – |
Q3 2020 | $107 | -12.3% | 40 | 0.0% | 0.00% | – |
Q2 2020 | $122 | +56.4% | 40 | 0.0% | 0.00% | – |
Q1 2020 | $78 | -31.6% | 40 | 0.0% | 0.00% | – |
Q4 2019 | $114 | -22.4% | 40 | 0.0% | 0.00% | – |
Q3 2019 | $147 | -11.4% | 40 | 0.0% | 0.00% | – |
Q2 2019 | $166 | -18.6% | 40 | 0.0% | 0.00% | – |
Q1 2019 | $204 | +48.9% | 40 | 0.0% | 0.00% | – |
Q4 2018 | $137 | -42.9% | 40 | 0.0% | 0.00% | – |
Q3 2018 | $240 | -5.5% | 40 | 0.0% | 0.00% | – |
Q2 2018 | $254 | +33.7% | 40 | 0.0% | 0.00% | – |
Q1 2018 | $190 | +41.8% | 40 | 0.0% | 0.00% | – |
Q4 2017 | $134 | +55.8% | 40 | 0.0% | 0.00% | – |
Q3 2017 | $86 | – | 40 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cutter & CO Brokerage, Inc. | 169,578 | $276,000 | 0.10% |
Geneos Wealth Management Inc. | 445,200 | $725,000 | 0.05% |
SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $20,000 | 0.01% |
Vivaldi Capital Management LP | 19,261 | $30,000 | 0.01% |
Atria Wealth Solutions, Inc. | 278,700 | $454,281 | 0.01% |
OSAIC HOLDINGS, INC. | 1,302,122 | $2,123,000 | 0.01% |
BARRETT & COMPANY, INC. | 4,984 | $5,632 | 0.00% |
Ameritas Advisory Services, LLC | 45,302 | $74,000 | 0.00% |
CENTAURUS FINANCIAL, INC. | 20,732 | $34,000 | 0.00% |
BENJAMIN F. EDWARDS & COMPANY, INC. | 19,255 | $31,000 | 0.00% |